The prevalence of Trichomonas vaginalis infection among patients that presented to hospitals in the Kermanshah district of Iran in 2006 and 2007

Turkish Journal of Medical Sciences

Volumn 40, Issue 6, 2010, Pages 971-975

  Chalechale, Abdolali ^a   Karimi, Isaac ^a  

^a RAZI UNIVERSITY   (Iran)

Author keywords

Iran; Pap smear; Season; Trichomoniasis

Indexed keywords

IRAN; OLD AGE; PAP SMEAR; PREVALENCE RATES; SEASON; SEASONAL DISTRIBUTIONS; SEASONAL VARIATION; TRICHOMONIASIS;

HOSPITALS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTUMN; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; INFECTION RATE; IRAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PELVIC EXAMINATION; PREVALENCE; RETROSPECTIVE STUDY; SEASONAL VARIATION; SPRING; SUMMER; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; WINTER;

EID: 79952155993     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-0906-18     Document Type: Article

References (28)

1. Schwebke JR, Burgess, D. Trichomoniasis. Clin Microbil Rev 2004; 17: 794-803.
2. Garland SM. Trichomonas vaginalis: why we should be screening. Venereology 2001; 14: 116-120.
3. Adu-Sarkodie Y. Trichomonas vaginalis screening goes global. Sex Transm Infect 2004; 80: 201-203.
4. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34: 519-522.
5. Grice AC. Vaginal infection causing spontaneous rupture of the membranes and premature delivery. Aust N Z J Obst Gynaecol 1974; 14: 156-158.
6. Wiwanitkit V. Counteraction during movement of spermatozoa by Trichomonas vaginalis observed by visual image analysis: a possible cause of female infertility. Fert Steril 2008; 90: 528-530.
7. Sutton MY, Sternberg M, Nsuami M, Behets F, Nelson AM, Louis MSt. Trichomoniasis in pregnant human immunodeficiency virus infected and human immunodeficiency virus-uninfected Congolese women: prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 1999; 181: 656-662.
8. Brown D Jr. Clinical variability of bacterial vaginosis and trichomoniasis. J Rep Mede 2004; 49: 781-786.
9. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 2009; 36: 11-16.
10. Viikki M, Pukkala E, Nieminen P, Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000; 39: 71-75.
11. Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD. Effects of bacterial vaginosis and other genital infections on the natural history of human papilloma virus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005; 191: 1129-1139.
12. Abdulazeez, A, Alo E, Livingstone R. Epidemiology of urinogenital trichomoniasis in a north-eastern State, Nigeria. The Internet J Parasitic Dis 2007; 2 (2).
13. Jamali R, Zareikar R, Kazemi A, Yousefee S, Ghazanchaei A, Estakhri Rasoul, Asgharzadeh M. Diagnosis of Trichomonas vaginalis infection using PCR method compared to culture and wet mount microscopy. Int Med J 2006; 5.
14. Bowden FJ, Garnett GP. Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment. Sex Transm Infect 2000; 76: 248-257.
15. Loo SK, Tang WY, Lo KK. Clinical significance of Trichomonas vaginalis detected in Papanicolaou smear: a survey in female Social Hygiene Clinic. Hong Kong Med J 2009; 15: 90-93.
16. Bakhtiari A, Hajian-Tilaki K, Pasha H. Genital infection by Trichomonas vaginalis in women referring to Babol health centers: prevalence and risk factors. IRCMJ 2008; 10: 16-21.
17. Xueqiang F, Yingzhi Z, Yandfang Y, Yutao D, Huiqing L. Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis of married women of child-bearing age in rural Shandong. Jpn J Infect Dis 2007; 60-257-261.
18. Al-Hindi AI, Lubbad AMH. Trichonamas vaginalis infection among Palestinian women: prevalence and trends during 2000-2006. Turk J Med Sci 2006; 36: 371-375.
19. Tanyüksel M, Gün H, Doganci L. Prevalence of Trichomonas vaginalis in prostitutes in Turkey. Cent Eur J Public Health 1996; 4: 96-97.
20. Madani AT. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis 2006; 6: 3.
21. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44: 13-22.
22. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2008; 200: 42.e1-7.
23. Crosby R, DiClemente R, Wingood G, Harrington K, Davies S, Hook E, Oh M. Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex Transm Infect 2002; 78: 360-364.
24. Weinstock H, Berman H, Cates W Jr. Sexually transmitted disease among American youth: incidence and prevalence estimates. Persp Sex Reprod Health 2004; 36: 6-10.
25. Neilson, R. Trichomonas vaginalis: II Laboratory investigations in trichomoniasis. Brit J Vener Dis 1973; 49: 531-535.
26. Schofield CBS. Seasonal variations in the reported incidence of sexually transmitted diseases in Scotland (1972-76). Brit J Vener Dis 1979; 55: 218-222.
27. Shrader S, Hernandez E, Gaughan J. Is there a seasonal difference in the detection of Trichomonas vaginalis by cytology. Sci World J 2003; 17: 45-50.
28. Nanda N, Michel RG, Kurdgelashvili G, Wendel KA: Trichomoniasis and its treatment. Expert Rev Anti Infect Ther 2006; 4: 125-35.